萨瑞普塔治疗 SRPT
$17.82 +$0.25 (+1.42%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $17.82 0.00%
开盘$18.77
昨收$17.57
当日区间$17.52 – $18.77
成交量2.60M
市值$1.91B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$401.25M-34.3% YoY
营业利润$52.29M-54.8% YoY
净利润-$4.89M-102.5% YoY
摊薄每股收益-$0.05-102.6% YoY
自由现金流$196.52M-14.5% YoY
经营现金流$197.07M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率59.1%
营业利润率-3.2%
净利率-6.9%
净资产收益率-9.5%
资产收益率-4.0%
投入资本回报率-4.3%
流动比率4.42
负债/资产比率52.1%
现金及投资$788.49M
总负债$1.05B
净现金（净负债）-$257.36M
自由现金流/营收3.8%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $401.25M | $730.80M | $2.20B | $442.93M | $399.36M |
| 营业总收入 | $401.25M | $730.80M | $2.20B | $442.93M | $399.36M |
| 营业成本 | $149.39M | $108.77M | $839.61M | $398.71M | $150.78M |
| 毛利润 | $251.87M | $622.04M | $1.36B | $44.23M | $248.58M |
| 营业费用 | $199.58M | $263.60M | $2.02B | $454.31M | $311.46M |
| 销售及管理费用 | $107.60M | $108.95M | $491.72M | $128.30M | $91.89M |
| -管理费用 | $107.60M | $108.95M | $491.72M | $128.30M | $91.89M |
| 研发费用 | $91.26M | $153.96M | $1.52B | $325.34M | $218.89M |
| 折旧、摊销与折耗 | $717,000.00 | $691,000.00 | $2.62M | $677,000.00 | $677,000.00 |
| -折旧与摊销 | $717,000.00 | $691,000.00 | $2.62M | $677,000.00 | $677,000.00 |
| 营业利润 | $52.29M | $358.43M | -$657.77M | -$410.08M | -$62.88M |
| 非经营性利息净收入（支出） | -$14.35M | -$14.71M | -$1.45M | -$12.10M | $816,000.00 |
| 非经营性利息收入 | $7.16M | $7.00M | $36.69M | $8.74M | $8.38M |
| 非经营性利息支出 | $21.51M | $21.71M | $38.14M | $20.84M | $7.57M |
| 其他收入（支出） | -$39.69M | -$548,000.00 | -$43.00M | $143.89M | -$131.99M |
| 证券出售收益 | -$448,000.00 | -$1.71M | -$15.91M | $1.35M | $36.74M |
| 特殊收益（费用） | -$39.00M | – | -$25.15M | $142.88M | -$168.02M |
| -减：其他特殊支出 | $39.00M | – | -$16.86M | -$155.48M | $138.61M |
| 其他非经营性收入（支出） | -$246,000.00 | $1.16M | -$1.94M | -$338,000.00 | -$702,000.00 |
| 税前利润 | -$1.75M | $343.17M | -$702.23M | -$278.30M | -$194.05M |
| 税费 | $3.14M | $12.22M | $11.19M | $4.55M | -$14.10M |
| 净利润 | -$4.89M | $330.96M | -$713.41M | -$282.85M | -$179.95M |
| 持续经营利润 | -$4.89M | $330.96M | -$713.41M | -$282.85M | -$179.95M |
| 归属母公司净利润 | -$4.89M | $330.96M | -$713.41M | -$282.85M | -$179.95M |
| 归属普通股股东净利润 | -$4.89M | $330.96M | -$713.41M | -$282.85M | -$179.95M |
| 基本每股收益 | -$0.05 | $3.15 | -$7.13 | -$3.93 | -$1.80 |
| 摊薄每股收益 | -$0.05 | $2.88 | -$7.13 | -$3.93 | -$1.80 |
| -减：重组及并购费用 | – | – | $42.01M | $12.60M | $29.41M |
| -减：核销 | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $3.19B | $3.18B | $3.35B | $3.35B | $3.49B |
| 流动资产合计 | $2.22B | $2.31B | $2.54B | $2.54B | $2.72B |
| 现金及现金等价物与短期投资 | $788.49M | $653.19M | $939.65M | $939.65M | $850.99M |
| -现金及现金等价物 | $571.15M | $464.45M | $801.28M | $801.28M | $613.08M |
| -短期投资 | $217.34M | $188.74M | $138.37M | $138.37M | $237.92M |
| 应收款 | $438.81M | $547.91M | $519.61M | $519.61M | $541.60M |
| -应收账款 | $376.82M | $394.82M | $398.23M | $398.23M | $395.74M |
| -应计应收利息 | $3.49M | $2.62M | $1.66M | $1.66M | $2.86M |
| -应收税款 | $13.49M | $14.03M | $15.60M | $15.60M | $14.30M |
| -其他应收款 | $45.02M | $136.45M | $104.12M | $104.12M | $128.71M |
| 预付资产 | $77.50M | $102.44M | $154.73M | $154.73M | $238.69M |
| 存货 | $904.27M | $1.00B | $914.74M | $914.74M | $1.08B |
| 其他流动资产 | $14.75M | $5.23M | $9.20M | $9.20M | $9.57M |
| 非流动资产合计 | $964.69M | $869.06M | $811.77M | $811.77M | $771.13M |
| 固定资产净值 | $446.84M | $460.30M | $470.62M | $470.62M | $498.10M |
| -固定资产原值 | $446.84M | $460.30M | $751.54M | $751.54M | $498.10M |
| 投资及预付款 | $151.72M | $89.73M | $10.57M | $10.57M | $9.21M |
| 一年以上预付资产 | $91.03M | $92.73M | $95.95M | $95.95M | $15.96M |
| 商誉及其他无形资产 | $30.61M | $31.38M | $28.95M | $28.95M | $29.68M |
| 一年以上递延资产 | $2.86M | $2.81M | $2.82M | $2.82M | $2.28M |
| 其他非流动资产 | $241.62M | $192.11M | $202.86M | $202.86M | $215.90M |
| 负债合计 | $1.66B | $1.67B | $2.21B | $2.21B | $2.17B |
| 流动负债合计 | $502.91M | $499.16M | $1.10B | $1.10B | $921.43M |
| 应付款 | $60.29M | $84.17M | $285.60M | $285.60M | $103.11M |
| -应付账款 | $50.98M | $70.38M | $280.84M | $280.84M | $94.02M |
| -应付税款合计 | $9.31M | $13.79M | $4.76M | $4.76M | $9.09M |
| 一年内应计费用 | $156.31M | $141.42M | $178.78M | $178.78M | $126.72M |
| 一年内预提费用 | $118.64M | $114.29M | $117.52M | $117.52M | $129.02M |
| 一年内递延负债 | $110.13M | $116.04M | $443.40M | $443.40M | $485.45M |
| 其他流动负债 | $16.56M | $10.38M | – | – | $46.17M |
| 非流动负债合计 | $1.16B | $1.17B | $1.11B | $1.11B | $1.25B |
| 长期债务及融资租赁负债 | $1.05B | $1.04B | $1.03B | $1.03B | $1.25B |
| -长期债务 | $847.62M | $838.16M | $828.97M | $828.97M | $1.04B |
| -长期融资租赁负债 | $198.23M | $198.51M | $199.38M | $199.38M | $215.04M |
| 一年以上递延负债 | $110.13M | $136.35M | $83.91M | $83.91M | $0.00 |
| 其他非流动负债 | $1.83M | $1.65M | $1.53M | $1.53M | $1.70M |
| 股东权益合计 | $1.53B | $1.51B | $1.14B | $1.14B | $1.32B |
| 股东权益 | $1.53B | $1.51B | $1.14B | $1.14B | $1.32B |
| 股本 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -普通股 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $6.10B | $6.08B | $6.04B | $6.04B | $5.99B |
| 留存收益 | -$4.55B | -$4.55B | -$4.88B | -$4.88B | -$4.64B |
| 减：库存股 | $25.26M | $25.26M | $25.26M | $25.26M | $25.26M |
| 不影响留存收益的损益 | -$565,000.00 | -$121,000.00 | $272,000.00 | $272,000.00 | $220,000.00 |
| -累计折旧 | – | – | -$280.92M | -$280.92M | – |
| -其他无形资产 | – | – | $28.95M | $28.95M | – |
| 短期债务及融资租赁负债 | – | – | $11.39M | $11.39M | – |
| -一年内到期融资租赁负债 | – | – | $11.39M | $11.39M | – |
| 一年内递延资产 | – | – | – | – | $4.29M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $197.07M | -$202.68M | -$205.48M | $131.21M | -$14.59M |
| 持续经营经营活动现金流净额 | $197.07M | -$202.68M | -$205.48M | $131.21M | -$14.59M |
| 持续经营净利润 | -$4.89M | $330.96M | -$713.41M | -$282.85M | -$179.95M |
| 持续经营损益 | $3.66M | $4.82M | $14.38M | -$141.75M | $94.17M |
| 折旧、折耗与摊销 | $10.41M | $10.59M | $44.52M | $5.25M | $18.45M |
| 其他非现金项目 | $9.38M | $8.32M | $70.59M | $16.15M | $51.14M |
| 营运资金变动 | $143.34M | -$586.25M | $78.04M | $339.51M | -$29.23M |
| -应收款变动 | $17.99M | $3.42M | $203.76M | -$2.49M | $131.56M |
| -存货变动 | $39.91M | -$69.76M | -$301.09M | $18.48M | -$83.02M |
| -预付资产变动 | $25.79M | $43.49M | $78.84M | $11.77M | -$1.80M |
| -应付账款及应计费用变动 | $3.30M | -$270.49M | $104.27M | $249.62M | -$87.77M |
| -其他流动资产变动 | $82.39M | -$14.55M | -$79.78M | $20.29M | -$62.81M |
| -其他流动负债变动 | $6.08M | -$3.44M | – | – | – |
| -其他营运资金变动 | -$32.13M | -$274.92M | $72.05M | $41.86M | $90.02M |
| 投资活动现金流净额 | -$93.37M | -$134.39M | $69.64M | $96.21M | $232.40M |
| 持续经营投资活动现金流净额 | -$93.37M | -$134.39M | $69.64M | $96.21M | $232.40M |
| 固定资产购置及出售净额 | -$555,000.00 | -$2.08M | -$101.97M | -$3.59M | -$22.93M |
| 无形资产购置及出售净额 | $0.00 | -$1.00M | -$7.88M | -$138,000.00 | -$5.74M |
| 投资购置及出售净额 | -$92.82M | -$131.31M | $5.39M | -$145.88M | $332.80M |
| 筹资活动现金流 | $0.00 | $241,000.00 | -$168.34M | -$39.21M | -$117.79M |
| 持续经营筹资活动现金流净额 | $0.00 | $241,000.00 | -$168.34M | -$39.21M | -$117.79M |
| 债务发行及偿还净额 | $0.00 | $0.00 | -$162.59M | -$35.13M | -$123.94M |
| 股票期权行使所得 | $0.00 | $241,000.00 | $18.70M | $308,000.00 | $1.21M |
| 期末现金余额 | $581.27M | $477.58M | $814.41M | $814.41M | $626.20M |
| 现金净变动 | $103.70M | -$336.83M | -$304.18M | $188.21M | $100.03M |
| 期初现金余额 | $477.58M | $814.41M | $1.12B | $626.20M | $526.18M |
| 自由现金流 | $196.52M | -$205.76M | -$315.33M | $127.48M | -$43.26M |
| 业务购买及出售净额 | – | $0.00 | $174.10M | $0.00 | – |
| 普通股发行净额 | – | – | -$5.01M | $0.00 | $20.00M |
| 其他筹资费用净额 | – | – | -$19.45M | -$4.38M | – |
暂无评论——快来第一个聊聊 SRPT。
登录后参与讨论。